University Hospital, Angers
Next generation sequencing (NGS) allows some better diagnostic results, particularly, in the rare diseases field. At a twenty five percent rate, those exams highlight some variants which are not yet described in human pathology. The relationship between a variant found inside a candidate gene and a pathology, is able to be confirmed by functional studies at a protein level. This study aims to build a biological collection to feed further functional studies to confirm the relationship between NGS identified variants, and the clinical signs and symptoms.
Rare Diseases
Genetic Disease
Skin biopsy, blood sample, urine sample
NA
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 1200 participants |
| Masking : | NONE |
| Primary Purpose : | DIAGNOSTIC |
| Official Title : | Functional Study to Indentify Genetic Etiology of Rare Diseases - ORIGIN |
| Actual Study Start Date : | 2022-10-10 |
| Estimated Primary Completion Date : | 2042-10-10 |
| Estimated Study Completion Date : | 2045-10-10 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
RECRUITING
Angers University Hospital Center
Angers, France, 49933